Latest filing published 22 Aug 2024 for CytomX Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Jeffrey B. Landau: trading record in brief
Jeffrey B. Landau discloses dealings in CytomX Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 19 July 2022 to 20 August 2024, the count stands at 12 filings.
On the market, this insider has only sold: 6 sales, €36k in total. Besides market trades, the filings include 4 share grants and 2 option exercises. Since January 2024: no purchases and 2 sales on the market.
Most recently, on 22 August 2024, the filings show an open-market sale worth €4,621 in CytomX Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey B. Landau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,250 shares0Common StockSEC:0001610717-24-000436:0
- 6,562 shares@ US$2.085561.5% of flowCommon StockSEC:0001610717-24-000175:0
- 30,000 shares0Common StockSEC:0001610717-24-000033:0
- 4,077 shares@ US$1.380525.0% of flowCommon StockSEC:0001610717-23-000421:0
- 11,250 shares0Common StockSEC:0001610717-23-000410:0
- 11,250 shares0Common StockSEC:0001610717-23-000298:0
- 1,477 shares@ US$1.979213.5% of flowCommon StockSEC:0001140361-23-012615:0
- 40,000 shares0Common StockSEC:0001567619-23-001929:0
- 11,250 shares0Common StockSEC:0001567619-22-014300:0
9 of 9 declarations